American Psychiatric Association. (2000). Diagnostic and statistical Manual of Mental disorders: DSM-IV, 4th ed., text revision (4th ed.). American Psychiatric Association.
Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical Cannabis laws and opioid analgesic Overdose mortality in the United States, 1999–2010. JAMA Intern Med, 174(10), 1668–1673. https://doi.org/10.1001/jamainternmed.2014.4005.
Article PubMed PubMed Central Google Scholar
Bradford, A. C., & Bradford, W. D. (2016). Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. Health Aff (Millwood), 35(7), 1230–1236. https://doi.org/10.1377/hlthaff.2015.1661.
Bradford, A. C., & Bradford, W. D. (2017). Medical marijuana laws may be associated with a decline in the number of prescriptions for Medicaid enrollees. Health Aff (Millwood), 36(5), 945–951. https://doi.org/10.1377/hlthaff.2016.1135.
Bradford, A. C., & Bradford, D. (2018). W. The impact of Medical Cannabis legalization on prescription medication use and costs under Medicare Part D. In Journal of Law and Economics (Vol. 61).
Bradford, A. C., Bradford, W. D., Abraham, A., & Adams, B., G (2018). Association between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Internal Medicine, 178(5), 667. https://doi.org/10.1001/jamainternmed.2018.0266.
Article PubMed PubMed Central Google Scholar
Caputi, T. L., & Humphreys, K. (2018). Medical Marijuana users are more likely to use prescription Drugs medically and nonmedically. Journal of Addiction Medicine, 12(4), 295–299. https://doi.org/10.1097/ADM.0000000000000405.
Center for Behavioral Health Statistics and Quality (2014). National Survey on Drug Use and Health: Methodological Resource Books. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health.
Centers for Disease Control and Prevention (2018, August 31). 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States Surveillance Special Report. Surveillance Special Report; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf.
Cerdá, M., Sarvet, A. L., Wall, M., Feng, T., Keyes, K. M., Galea, S., & Hasin, D. S. (2018). Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription Drugs, and other illicit Drugs. Drug and Alcohol Dependence, 183, 62–68. https://doi.org/10.1016/j.drugalcdep.2017.10.021.
Cerdá, M., Mauro, C., Hamilton, A., Levy, N. S., Santaella-Tenorio, J., Hasin, D., Wall, M. M., Keyes, K. M., & Martins, S. S. (2020). Association between Recreational Marijuana Legalization in the United States and Changes in Marijuana Use and Cannabis Use Disorder from 2008 to 2016. JAMA Psychiatry, 77(2), 165. https://doi.org/10.1001/jamapsychiatry.2019.3254.
Davis, C. S., & Lieberman, A. J. (2021). Laws limiting prescribing and dispensing of opioids in the United States, 1989–2019. Addiction, 116(7), 1817–1827. https://doi.org/10.1111/add.15359.
Gorfinkel, L. R., Stohl, M., Greenstein, E., Aharonovich, E., Olfson, M., & Hasin, D. (2020). Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis. Addiction, 116, 1113–1121. https://doi.org/10.1111/add.15228.
Article PubMed PubMed Central Google Scholar
Gukasyan, N., & Strain, E. C. (2020). Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012–2017. Drug and Alcohol Dependence, 208, 2012–2017. https://doi.org/10.1016/j.drugalcdep.2020.107867.
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and Use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865.
Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017). US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana laws: 1991–1992 to 2012–2013. JAMA Psychiatry, 74(6), 579–588. https://doi.org/10.1001/jamapsychiatry.2017.0724.
Article PubMed PubMed Central Google Scholar
Horwitz, J. R., Davis, C., McClelland, L., Fordon, R., & Meara, E. (2020). The importance of data source in prescription drug monitoring program research. Health Services Research, 1–7. https://doi.org/10.1111/1475-6773.13548.
Ishida, J. H., Wongid, P. O., Cohen, B. E., Vali, M., Steigerwald, S., & Keyhaniid, S. (2019). Substitution of marijuana for opioids in a national survey of US adults. PLoS One, 14(10), e0222577. https://doi.org/10.1371/journal.pone.0222577.
Article CAS PubMed PubMed Central Google Scholar
McGinty, E. E., Bicket, M. C., Seewald, N. J., Stuart, E. A., Alexander, G. C., Barry, C. L., McCourt, A. D., & Rutkow, L. (2022). Effects of State Opioid Prescribing laws on Use of Opioid and other Pain treatments among commercially insured U.S. adults. Annals of Internal Medicine, 175(5), 617–627. https://doi.org/10.7326/m21-4363.
Article PubMed PubMed Central Google Scholar
McMichael, B. J., Van Horn, R. L., & Viscusi, W. K. (2020). The impact of cannabis access laws on opioid prescribing. Journal of Health Economics, 69, 1–18. https://doi.org/10.1016/J.JHEALECO.2019.102273.
Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2018). Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD012182.pub2.
Article PubMed PubMed Central Google Scholar
Olfson, M., Wall, M. M., Liu, S. M., & Blanco, C. (2018). Cannabis Use and risk of prescription opioid use disorder in the United States. American Journal of Psychiatry, 175(1), 47–53. https://doi.org/10.1176/appi.ajp.2017.17040413.
Pacula, R. L., & Smart, R. (2017). Medical marijuana and marijuana legalization. Annual Review of Clinical Psychology, 13, 397–419. https://doi.org/10.1146/annurev-clinpsy-032816-045128.
Article PubMed PubMed Central Google Scholar
Powell, D., Pacula, R. L., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42. https://doi.org/10.1016/j.jhealeco.2017.12.007.
Article PubMed PubMed Central Google Scholar
Rabe-Hesketh, S., & Skrondal, A. (2006). Multilevel modelling of complex survey data. In Journal of the Royal Statistical Society (Vol. 169).
Reiman, A., Welty, M., & Solomon, P. (2017). Cannabis as a substitute for opioid-based Pain Medication: Patient self-report. Cannabis and Cannabinoid Research, 2(1), 160–166. https://doi.org/10.1089/can.2017.0012.
Article PubMed PubMed Central Google Scholar
Schmid, I., Stuart, E. A., McCourt, A. D., Tormohlen, K. N., Stone, E. M., Davis, C. S., Bicket, M. C., & McGinty, E. E. (2022). Effects of state opioid prescribing cap laws on opioid prescribing after Surgery. Health Services Research, 57(5), 1154–1164. https://doi.org/10.1111/1475-6773.14023.
Article PubMed PubMed Central Google Scholar
Segura, L. E., Mauro, C. M., Levy, N. S., Khauli, N., Philbin, M. M., Mauro, P. M., & Martins, S. S. (2019). Association of US medical marijuana laws with nonmedical prescription opioid use and prescription opioid use disorder. JAMA Network Open, 2(7), e197216. https://doi.org/10.1001/jamanetworkopen.2019.7216.
Article PubMed PubMed Central Google Scholar
Shover, C. L., Davis, C. S., Gordon, S. C., Humphreys, K., & Wachter, K. W. (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1903434116.
Spencer, M. R., Miniño, A. M., & Warner, M. (2022). Drug Overdose deaths in the United States, 2001–2021. Nchs Data Brief, 457.
StataCorp. (2019). Stata Statistical Software: Release 16. StataCorp LLC. No. 15.
Stone, E. M., Tormohlen, K. N., McCourt, A. D., Schmid, I., Stuart, E. A., Davis, C. S., Bicket, M. C., & McGinty, E. E. (2022). Association between State Opioid Prescribing Cap laws and receipt of opioid prescriptions among children and adolescents. JAMA Health Forum, 3(8), e222461. https://doi.org/10.1001/jamahealthforum.2022.2461.
Article PubMed PubMed Central Google Scholar
United States Census Bureau. (2010). 2010 Census. U.S. Census Bureau.
Wen, H., & Hockenberry, J. M. (2018). Association of Medical and Adult-Use Marijuana laws with Opioid Prescribing for Medicaid Enrollees. JAMA Internal Medicine, 178(5), 673–679. https://doi.org/10.1001/jamainternmed.2018.1007.
Article PubMed PubMed Central Google Scholar
Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80. https://doi.org/10.1016/J.JHEALECO.2015.03.007.
Wen, J., Wen, H., Butler, J. S., & Talbert, J. C. (2021). The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance. Health Economics, 30(5), 989–1000. https://doi.org/10.1002/hec.4237.
Article PubMed PubMed Central Google Scholar
Wiese, B., & Wilson-Poe, A. R. (2018). Emerging evidence for Cannabis’ Role in Opioid Use Disorder. Cannabis and Cannabinoid Research, 3(1), 179–189. https://doi.org/10.1089/can.2018.0022.
Article CAS PubMed PubMed Central Google Scholar
Wilson, J., Mills, K., Freeman, T. P., Sunderland, M., Visontay, R., & Marel, C. (2021). Weeding out the truth: A systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction. https://doi.org/10.1111/add.15581.
Article PubMed PubMed Central Google Scholar
Wong, S. S. C., Chan, W. S., & Cheung, C. W. (2020). Analgesic effects of cannabinoids for Chronic Non-cancer Pain: A systematic review and Meta-analysis with Meta-regression. Journal of Neuroimmune Pharmacology, 15, 801–829. https://doi.org/10.1007/s11481-020-09905-y.
Comments (0)